scholarly journals Deregulation of Lipid Homeostasis: A Fa(c)t in the Development of Metabolic Diseases

Cells ◽  
2020 ◽  
Vol 9 (12) ◽  
pp. 2605
Author(s):  
Sabina Cisa-Wieczorek ◽  
María Isabel Hernández-Alvarez

Lipids are important molecules for human health. The quantity and quality of fats consumed in the diet have important effects on the modulation of both the natural biosynthesis and degradation of lipids. There is an important number of lipid-failed associated metabolic diseases and an increasing number of studies suggesting that certain types of lipids might be beneficial to the treatment of many metabolic diseases. The aim of the present work is to expose an overview of de novo biosynthesis, storage, and degradation of lipids in mammalian cells, as well as, to review the published data describing the beneficial effects of these processes and the potential of some dietary lipids to improve metabolic diseases.

RSC Advances ◽  
2019 ◽  
Vol 9 (52) ◽  
pp. 30087-30099 ◽  
Author(s):  
Xiao-Dan Yin ◽  
Yu Sun ◽  
Raymond Kobla Lawoe ◽  
Guan-Zhou Yang ◽  
Ying-Qian Liu ◽  
...  

Phytopathogenic fungi have become a serious threat to the quality of agricultural products, food security and human health globally, necessitating the need to discover new antifungal agents with de novo chemical scaffolds and high efficiency.


2013 ◽  
Vol 6 ◽  
pp. LPI.S10862 ◽  
Author(s):  
Kelsey D. Jordan ◽  
Rita K. Upmacis

Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid (PUFA) with 20 carbon atoms and 5 carbon-carbon double bonds. Mammalian cells cannot synthesize long chain PUFAs such as EPA de novo, and, thus, the most effective way to enrich cells in EPA is by dietary intake of fish oils. EPA supplementation causes an increase in its concentration in plasma lipids and in cell membrane phospholipids. Many beneficial effects of EPA supplementation have been noted, including (1) the potential to sensitize cancerous tumors towards chemotherapy, (2) the promotion of cardiovascular health, and (3) the alleviation of some mental disorders, but results from clinical trials have sometimes been disparate. In this study, we report the use of mass spectrometry to investigate the autoxidation of EPA, thereby demonstrating the formation of a variety of oxidized products. The oxidative stress of the patient may affect the response to EPA and may, in part, explain divergent results from clinical trials.


2006 ◽  
Vol 18 (10) ◽  
pp. 1779-1792 ◽  
Author(s):  
Evgeny V. Berdyshev ◽  
Irina A. Gorshkova ◽  
Peter Usatyuk ◽  
Yutong Zhao ◽  
Bahman Saatian ◽  
...  

Molecules ◽  
2020 ◽  
Vol 25 (18) ◽  
pp. 4182
Author(s):  
Daniela Gabbia ◽  
Sara De Martin

Metabolic syndrome is characterized by the coexistence of different metabolic disorders which increase the risk of developing type 2 diabetes mellitus and cardiovascular diseases. Therefore, metabolic syndrome leads to a reduction in patients’ quality of life as well as to an increase in morbidity and mortality. In the last few decades, it has been demonstrated that seaweeds exert multiple beneficial effects by virtue of their micro- and macronutrient content, which could help in the management of cardiovascular and metabolic diseases. This review aims to provide an updated overview on the potential of brown seaweeds for the prevention and management of metabolic syndrome and its associated diseases, based on the most recent evidence obtained from in vitro and in vivo preclinical and clinical studies. Owing to their great potential for health benefits, brown seaweeds are successfully used in some nutraceuticals and functional foods for treating metabolic syndrome comorbidities. However, some issues still need to be tackled and deepened to improve the knowledge of their ADME/Tox profile in humans, in particular by finding validated indexes of their absorption and obtaining reliable information on their efficacy and long-term safety.


2016 ◽  
Vol 212 (6) ◽  
pp. 621-631 ◽  
Author(s):  
Ariadna P. Velázquez ◽  
Takashi Tatsuta ◽  
Ruben Ghillebert ◽  
Ingmar Drescher ◽  
Martin Graef

Lipid droplets (LDs) are conserved organelles for intracellular neutral lipid storage. Recent studies suggest that LDs function as direct lipid sources for autophagy, a central catabolic process in homeostasis and stress response. Here, we demonstrate that LDs are dispensable as a membrane source for autophagy, but fulfill critical functions for endoplasmic reticulum (ER) homeostasis linked to autophagy regulation. In the absence of LDs, yeast cells display alterations in their phospholipid composition and fail to buffer de novo fatty acid (FA) synthesis causing chronic stress and morphologic changes in the ER. These defects compromise regulation of autophagy, including formation of multiple aberrant Atg8 puncta and drastically impaired autophagosome biogenesis, leading to severe defects in nutrient stress survival. Importantly, metabolically corrected phospholipid composition and improved FA resistance of LD-deficient cells cure autophagy and cell survival. Together, our findings provide novel insight into the complex interrelation between LD-mediated lipid homeostasis and the regulation of autophagy potentially relevant for neurodegenerative and metabolic diseases.


2021 ◽  
Vol 22 (23) ◽  
pp. 13063
Author(s):  
Georg Aichinger

Natural dibenzo-α-pyrones (DAPs) can be viewed from two opposite angles. From one angle, the gastrointestinal metabolites urolithins are regarded as beneficial, while from the other, the emerging mycotoxin alternariol and related fungal metabolites are evaluated critically with regards to potential hazardous effects. Thus, the important question is: can the structural characteristics of DAP subgroups be held responsible for distinct bioactivity patterns? If not, certain toxicological and/or pharmacological aspects of natural DAPs might yet await elucidation. Thus, this review focuses on comparing published data on the two groups of natural DAPs regarding both adverse and beneficial effects on human health. Literature on genotoxic, estrogenic, endocrine-disruptive effects, as well as on the induction of the cellular anti-oxidative defense system, anti-inflammatory properties, the inhibition of kinases, the activation of mitophagy and the induction of autophagy, is gathered and critically reviewed. Indeed, comparing published data suggests similar bioactivity profiles of alternariol and urolithin A. Thus, the current stratification into hazardous Alternaria toxins and healthy urolithins seems debatable. An extrapolation of bioactivities to the other DAP sub-class could serve as a promising base for further research. Conclusively, urolithins should be further evaluated toward high-dose toxicity, while alternariol derivatives could be promising chemicals for the development of therapeutics.


2006 ◽  
Vol 54 (2) ◽  
pp. S345.3-S345
Author(s):  
E. Berdyshev ◽  
I. Gorshkova ◽  
P. Usatyuk ◽  
Y. Zhao ◽  
B. Saatian ◽  
...  

1997 ◽  
Vol 78 (1) ◽  
pp. S15-S35 ◽  
Author(s):  
Michel Doreau ◽  
Yves Chilliard

Fat digestion and metabolism differ widely between animal species. In ruminants, dietary fats are hydrogenated in the rumen before intestinal absorption so that absorbed fatty acids (FA) are more saturated than dietary FA. In non-ruminants, intestinal FA digestibility depends on the level of saturation of dietary FA. Fat supplementation of the diet of cows decreases milk protein and has a variable effect on milk fat, depending on the source of dietary lipids. When encapsulated lipids are used, the linoleic acid content of milk is increased, but the organoleptic quality of milk may be altered. Supplementary lipids are incorporated into non-ruminant body fat, whereasde novolipogenesis is reduced. There is a close relationship between the nature of dietary FA and non-ruminant body FA.


2006 ◽  
Vol 20 (4) ◽  
Author(s):  
E. Berdyshev ◽  
I. Gorshkova ◽  
P. Usatyuk ◽  
Y. Zhao ◽  
B. Saatian ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document